BioSpace News Archive

CQDM, the Quebec Breast Cancer Foundation and Theratechnologies announced close to CAN $2 million of funding for a collaborative research project that aims to demonstrate the efficacy and safety of a potential innovative treatment for patients affected by metastatic cancer.

Dyne Therapeutics, Inc. today announced that the New Zealand Medicines and Medical Devices Safety Authority cleared its clinical trial application to initiate its Phase 1/2 multiple ascending dose (MAD) clinical trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1).

Green Scientific Labs Holdings Inc. (“Green Scientific Labs” or the “Company”), leading multi-state provider of innovative cannabis and hemp testing technologies and methods, was assessed on Thursday, July 7 by an ISO accreditation body for its initial accreditation.

Accuray Incorporated (NASDAQ: ARAY) announced today that new clinical studies presented at the 15th Congress of the International Stereotactic Radiosurgery Society (ISRS) in Milan, Italy reinforce the value of the company’s CyberKnife® platform in the treatment of neurological indications with non-invasive radiosurgery.

Akanda Corp. (“Akanda”) (NASDAQ: AKAN) and Tetra Bio-Pharma (“Tetra”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), today jointly announced that Akanda will supply Tetra with pharmaceutical grade cannabis flower in a microdose cap form, for use in a Storz & Bickel Mighty Medic Vaporizer for global commercialization of Tetra’s QIXLEEFTM and related products

Forma Therapeutics Holdings, Inc. today announced that its Board of Directors granted to Agustín Melián, M.D. and Linea Aspesi non-qualified stock options of 118,000 and 59,000 shares, respectively, of its common stock.

AngioDynamics, Inc. today announced financial results for the fourth quarter and fiscal year 2022, which ended May 31, 2022.

Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants, today announced the FDA clearance of a new Lumbar Spinal Stenosis Indication for Use for its ZIP™ family of MIS implants.

M2GEN today announced the appointment of Melissa Honour, MPH, to its executive leadership team as Chief Product Officer.

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced an agreement with InfYnity Biomarkers, an R&D firm dedicated to utilizing biomarkers for the management of infectious and immunology diseases, under which the two companies will partner to advance the safety and effectiveness of infectious disease testing by leveraging Quotient’s MosaiQ solution.